GlassScriptPhysician profile
Angela Karsten
NPI 1851652028
$4,472.60
in general payments reported to CMS, 2019-2025
39 companies · $733 in 2025
The $733 reported for 2025 was more than what 80% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $858 · 2022: $904 · 2023: $1,207 · 2024: $771 · 2025: $733.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,631 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,630.60 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $426.98 | 2022-2025 | |
| 180 Medical, INC. | $380.74 | 2021-2025 | Gentlecath, Cure Ultra Catheter, Gentlecath Glide |
| Astellas Pharma US INC | $329.31 | 2021-2025 | Xtandi, Myrbetriq |
| Janssen Biotech, INC. | $323.70 | 2022-2025 | Erleada, Akeega |
| Teleflex LLC | $245.94 | 2022-2024 | Urolift |
| Urogen Pharma, INC. | $222.50 | 2021-2025 | Jelmyto |
| Merck Sharp & Dohme LLC | $209.79 | 2021-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Dendreon Pharmaceuticals LLC | $203.04 | 2021-2025 | Provenge |
| Boston Scientific Corporation | $190.27 | 2021-2025 | Rezum Generator, Lithovue, Spaceoar Vue System - 10ml |
| Bayer Healthcare Pharmaceuticals INC. | $181.39 | 2021-2023 | |
| Sumitomo Pharma America, INC. | $161.15 | 2023-2025 | Gemtesa, Orgovyx |
| Calyxo, INC. | $145.71 | 2025 | Cvac Aspiration System |
| Tolmar Pharmaceuticals, INC. | $142.68 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $120.90 | 2021-2023 | Aveed, Xiaflex |
| Janssen Scientific Affairs, LLC | $117.78 | 2023 | Pipeline, Erleada, Balversa |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar, INC. | $100.33 | 2023-2025 | Eligard, Jatenzo |
| Accord Healthcare, INC. | $85.98 | 2022-2024 | |
| Procept Biorobotics Corporation | $73.49 | 2022-2024 | Aquabeam System |
| Pfizer INC. | $67.76 | 2021-2025 | |
| Coloplast Corp | $64.59 | 2023-2024 | Speedicath |
| C. R. Bard, INC. & Subsidiaries | $63.67 | 2023-2025 | Bard Urinary Drainage Bag, Purewick Female External Catheter |
| Urovant Sciences INC | $61.55 | 2021-2022 | |
| Verity Pharmaceuticals INC. | $53.35 | 2023-2024 | Trelstar |
| Myovant Sciences INC. | $50.59 | 2022 | |
| Ferring Pharmaceuticals INC. | $48.90 | 2025 | Adstiladrin |
| Photocure INC | $48.67 | 2022-2023 | Cysview |
| Becton, Dickinson and Company | $44.65 | 2023-2024 | Bard Urinary Drainage Bag |
| Endo USA, INC. | $41.51 | 2024-2025 | Xiaflex |
| Karl Storz Endoscopy-America | $40.32 | 2022 | |
| Rochester Medical Corporation | $38.70 | 2021 | |
| Blue Earth Diagnostics | $31.71 | 2021-2022 | |
| Palette Life Sciences, INC. | $27.71 | 2022 | |
| Smith+Nephew, INC. | $26.15 | 2023 | Stravix |
| Allergan, INC. | $25.28 | 2021-2022 | |
| Antares Pharma, INC. | $20.62 | 2022 | |
| Immunitybio, INC. | $20.58 | 2024 | |
| Novartis Pharmaceuticals Corporation | $17.67 | 2024 | |
| Progenics Pharmaceuticals, INC. | $15.84 | 2024 | |
| Travere Therapeutics, INC. | $1.10 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Karsten listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.